volume 11 issue 3 pages 229-245

GABAA receptor family: overview on structural characterization

Publication typeJournal Article
Publication date2019-02-25
scimago Q3
wos Q2
SJR0.501
CiteScore4.8
Impact factor3.4
ISSN17568919, 17568927
Drug Discovery
Pharmacology
Molecular Medicine
Abstract

The pentameric γ-aminobutyric acid type A receptors are ion channels activated by ligands, which intervene in the rapid inhibitory transmission in the mammalian CNS. Due to their rich pharmacology and therapeutic potential, it is essential to understand their structure and function thoroughly. This deep characterization was hampered by the lack of experimental structural information for many years. Thus, computational techniques have been extensively combined with experimental data, in order to undertake the study of γ-aminobutyric acid type A receptors and their interaction with drugs. Here, we review the exciting journey made to assess the structures of these receptors and outline major outcomes. Finally, we discuss the brand new structure of the α1β2γ2 subtype and the amazing advances it brings to the field.

Found 
Found 

Top-30

Journals

1
Nutrients
1 publication, 7.14%
Frontiers in Cellular Neuroscience
1 publication, 7.14%
Cellular and Molecular Life Sciences
1 publication, 7.14%
Computational and Structural Biotechnology Journal
1 publication, 7.14%
ACS Omega
1 publication, 7.14%
Expert Opinion on Therapeutic Patents
1 publication, 7.14%
Farmatsiya i Farmakologiya
1 publication, 7.14%
Journal of Molecular Neuroscience
1 publication, 7.14%
Pest Management Science
1 publication, 7.14%
Mendeleev Communications
1 publication, 7.14%
Quarterly Reviews of Biophysics
1 publication, 7.14%
Proteins: Structure, Function and Genetics
1 publication, 7.14%
Molecules
1 publication, 7.14%
1

Publishers

1
2
MDPI
2 publications, 14.29%
Springer Nature
2 publications, 14.29%
Wiley
2 publications, 14.29%
Frontiers Media S.A.
1 publication, 7.14%
Elsevier
1 publication, 7.14%
American Chemical Society (ACS)
1 publication, 7.14%
Taylor & Francis
1 publication, 7.14%
Cold Spring Harbor Laboratory
1 publication, 7.14%
Volgograd State Medical University
1 publication, 7.14%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 7.14%
Cambridge University Press
1 publication, 7.14%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
14
Share
Cite this
GOST |
Cite this
GOST Copy
Amundarain M. J. et al. GABAA receptor family: overview on structural characterization // Future Medicinal Chemistry. 2019. Vol. 11. No. 3. pp. 229-245.
GOST all authors (up to 50) Copy
Amundarain M. J., Ribeiro R. P., Costabel M. D., Giorgetti A. GABAA receptor family: overview on structural characterization // Future Medicinal Chemistry. 2019. Vol. 11. No. 3. pp. 229-245.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.4155/fmc-2018-0336
UR - https://doi.org/10.4155/fmc-2018-0336
TI - GABAA receptor family: overview on structural characterization
T2 - Future Medicinal Chemistry
AU - Amundarain, María Julia
AU - Ribeiro, Rui Pedro
AU - Costabel, Marcelo Daniel
AU - Giorgetti, Alejandro
PY - 2019
DA - 2019/02/25
PB - Taylor & Francis
SP - 229-245
IS - 3
VL - 11
PMID - 30801199
SN - 1756-8919
SN - 1756-8927
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Amundarain,
author = {María Julia Amundarain and Rui Pedro Ribeiro and Marcelo Daniel Costabel and Alejandro Giorgetti},
title = {GABAA receptor family: overview on structural characterization},
journal = {Future Medicinal Chemistry},
year = {2019},
volume = {11},
publisher = {Taylor & Francis},
month = {feb},
url = {https://doi.org/10.4155/fmc-2018-0336},
number = {3},
pages = {229--245},
doi = {10.4155/fmc-2018-0336}
}
MLA
Cite this
MLA Copy
Amundarain, María Julia, et al. “GABAA receptor family: overview on structural characterization.” Future Medicinal Chemistry, vol. 11, no. 3, Feb. 2019, pp. 229-245. https://doi.org/10.4155/fmc-2018-0336.